Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-12-08Clinical Trial Update: Combination of AUY922 With Trastuzumab in HER2+ Advanced Breast Cancer Patients Previously Treated With Trastuzumab [Phase 1, Phase 2]
A Phase 1/2 study evaluating AUY922 in combination with trastuzumab in patients with advanced HER2-positive breast cancer previously treated…
-
CLINICAL_TRIALS trial_result · 2020-12-07Clinical Trial Update: Case Collection Study to Support Digital Mammography Image Software Change [NA]
A completed case collection study evaluating a digital mammography image software change for breast cancer imaging; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-12-04Clinical Trial Update: Docetaxel, Doxorubicin (A), Cyclophosphamide (C) (TAC) vs 5-Fluorouracil, A, C (5FAC) Breast Cancer Adjuvant Treatment [Phase 3]
Phase 3 trial comparing TAC (Docetaxel, Doxorubicin, Cyclophosphamide) versus 5FAC (5-Fluorouracil, Doxorubicin, Cyclophosphamide) as adjuva…
-
CLINICAL_TRIALS trial_result · 2020-12-04Clinical Trial Update: Tamoxifen or Letrozole in Treating Women With Ductal Carcinoma in Situ [Phase 1, Phase 2]
Phase 1/2 trial evaluating tamoxifen or letrozole for ductal carcinoma in situ completed; results posted.
-
CLINICAL_TRIALS trial_result · 2020-12-03Clinical Trial Update: Maintenance Aromatase Inhibitors (AIs)+ Everolimus vs AIs in Hormone Receptor Positive Metastatic Breast Cancer Patients [Phase 3]
Phase 3 trial comparing maintenance aromatase inhibitors with and without everolimus in hormone receptor-positive metastatic breast cancer; …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-12-03Clinical Trial Update: Brief Behavioral Intervention for Insomnia During Chemotherapy [NA]
A completed clinical trial assessing a brief behavioral intervention for insomnia during chemotherapy in breast cancer patients, with result…
-
CLINICAL_TRIALS trial_result · 2020-12-02Clinical Trial Update: Combination Immunotherapy With Herceptin and the HER2 Vaccine NeuVax [Phase 2]
Phase 2 trial evaluating combination immunotherapy with Herceptin and the HER2 vaccine NeuVax in breast cancer has completed with results po…
-
CLINICAL_TRIALS trial_result · 2020-12-02Clinical Trial Update: Apatinib Combined With Oral Etoposide in Metastatic HER2 Negative Breast Cancer [Phase 2]
Phase 2 trial evaluating apatinib combined with oral etoposide in metastatic HER2-negative breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2020-12-02Clinical Trial Update: 4-weekly Versus 12-weekly Administration of Bone-targeted Agents in Patients With Bone Metastases [Phase 4]
Phase 4 trial comparing 4-weekly versus 12-weekly administration of bone-targeted agents in patients with bone metastases.
-
CLINICAL_TRIALS trial_result · 2020-11-30Clinical Trial Update: Fulvestrant or Capecitabine Combined With Pyrotinib in HR+/HER2+ Metastatic Breast Cancer [Phase 3]
A Phase 3 trial evaluating fulvestrant or capecitabine in combination with pyrotinib for HR+/HER2+ metastatic breast cancer is currently rec…
-
CLINICAL_TRIALS trial_result · 2020-11-27Clinical Trial Update: Neoadjuvant Letrozole and Palbociclib in Patients With Stage II-IIIB Breast Cancer, HR+, HER2 - [Phase 2]
Phase 2 trial update evaluating neoadjuvant letrozole with palbociclib in stage II-IIIB HR+, HER2-negative breast cancer.
-
CLINICAL_TRIALS trial_result · 2020-11-27Clinical Trial Update: KORTUC: Intra-tumoural Hydrogen Peroxide as a Radiation Sensitizer in Patients With Locally Advanced/Recurrent Breast Cancer in Terms of Toxicity and Tumour Response [Phase 1, Phase 2]
A Phase 1/2 trial evaluating intra-tumoural hydrogen peroxide (KORTUC) as a radiation sensitizer in locally advanced or recurrent breast can…
-
CLINICAL_TRIALS trial_result · 2020-11-23Clinical Trial Update: Study of Concurrent Paclitaxel and Radiation: Correlation of Tumor Profiles With Pathologic Response [Phase 2]
Phase 2 trial evaluating concurrent paclitaxel and radiation in breast cancer with analysis of tumor profiles and pathologic response.
-
CLINICAL_TRIALS trial_result · 2020-11-20Clinical Trial Update: Reducing Metabolic Syndrome Among Breast Cancer Survivors [NA]
Clinical trial update on reducing metabolic syndrome among breast cancer survivors; study completed with posted results in 2020.
-
CLINICAL_TRIALS trial_result · 2020-11-20Clinical Trial Update: Pyrotinib, Trastuzumab And Abraxane in HER2-positive MBC With Brain Metastasis [Phase 2]
Phase 2 trial update involving pyrotinib, trastuzumab, and Abraxane for HER2-positive metastatic breast cancer with brain metastases.
-
CLINICAL_TRIALS trial_result · 2020-11-19Clinical Trial Update: Succinylated Gelatin for Prevention of Fluid Retention in Patients With Breast Cancer Receiving Docetaxel Chemotherapy [Phase 2]
Phase 2 trial update evaluating succinylated gelatin to prevent fluid retention in patients with breast cancer receiving docetaxel chemother…
-
CLINICAL_TRIALS trial_result · 2020-11-18Clinical Trial Update: Neoadjuvant Treatment With Nab-paclitaxel for Patients With Stage II and III Luminal Breast Cancer [Phase 2]
Phase 2 trial update on neoadjuvant nab-paclitaxel for stage II/III luminal breast cancer has completed recruitment with results posted.
-
FDA approval · 2020-11-17FDA Approved: FULVESTRANT — Original Application (Accord Healthcare Inc.)
FDA approves Accord Healthcare's Original Application for a generic fulvestrant (Fulvestrant) for the treatment of metastatic breast cancer.
-
CLINICAL_TRIALS trial_result · 2020-11-16Clinical Trial Update: Vaccine Therapy and QS21 in Treating Patients With Metastatic Breast Cancer [NA]
Clinical trial update for a vaccine therapy with QS21 in metastatic breast cancer; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-11-13Clinical Trial Update: A Study of R1507 in Combination With Letrozole in Postmenopausal Women With Advanced Breast Cancer [Phase 2]
A Phase 2 trial evaluating R1507 in combination with letrozole for postmenopausal women with advanced breast cancer has been terminated, wit…
-
CLINICAL_TRIALS trial_result · 2020-11-04Clinical Trial Update: The ConnectedCancerCare Pilot Study (CCC) [NA]
A completed early-stage breast cancer trial (CCC Pilot Study) with results posted in 2020, focusing on survivorship and transitional care.
-
CLINICAL_TRIALS trial_result · 2020-11-03Clinical Trial Update: Effect of a Topical Ketamine on Acute and Chronic Pain, Dose Finding [Phase 2, Phase 3]
Phase 2/3 clinical trial investigating topical ketamine for acute and chronic pain in breast cancer patients is completed.
-
CLINICAL_TRIALS trial_result · 2020-11-03Clinical Trial Update: SentiMag® Intraoperative Comparison in Breast Cancer [NA]
Clinical trial update for SentiMag intraoperative comparison in breast cancer study completed with results posted.
-
CLINICAL_TRIALS withdrawal · 2020-10-30Clinical Trial Update: Evaluate the Safety, Tolerability, Biodistribution and Anti Tumour Activity of 177LU-OPS201 With Companion Imaging 68Ga-OPS202 PET/CT in Previously Treated Subjects With Locally Advanced or Metastatic Cancers Expressing Somatostatin Receptor 2 (SSTR2) [Phase 1, Phase 2]
Phase 1/2 trial evaluating 177Lu-OPS201 with 68Ga-OPS202 imaging in somatostatin receptor 2–expressing cancers; study terminated with posted…
-
FDA approval · 2020-10-28FDA Approved: ANASTROZOLE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for ANASTROZOLE from Teva Pharmaceuticals USA, Inc. This action approves the supplemental submission…